Search

everythinglearnresearchcommunity

for

Search:↓

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Early diagnosis and treatment of myositis in SLE patients lead to positive outcomes.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Genetic analysis of rabbits identified key genes for traits like coat color, body size, and fertility.

Early detection and treatment of primary biliary cirrhosis and related autoimmune diseases improve outcomes.

SII is a useful and affordable tool to assess and monitor alopecia areata.

CS12192 effectively treats alopecia areata with better safety than current options.

AgK114 protein helps in hamster skin injury recovery.

Patients with thyroid disorders show different symptoms and antibody levels.

Scientists found a new protein, AMY117, common in Alzheimer's patients, which could be important for treatment and diagnosis.

Systemic sclerosis skin shows varied gene patterns, suggesting potential for personalized treatment.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

Ostrich antibodies are a promising, cost-effective treatment for various skin diseases and conditions.

Hair germ cells differ from epidermal cells in keratin expression, and specific keratins form after hair differentiation.

Relatives of lupus patients show signs of immune system activity but not full-blown lupus.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

Biosimilars lower costs but don't significantly improve access.

The document concludes that systemic autoimmune diseases are complex, incurable, and require ongoing treatment and research.

Blocking α-toxin helps heal Staphylococcus aureus-infected wounds faster in both normal and diabetic mice, with different effects on their immune responses.

Recombinant thymosin β4 promotes blood vessel growth and reduces muscle damage.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

The method effectively delivers vaccines through the skin without needles.

Higher FABP4 levels may help diagnose androgenetic alopecia early.